Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/23933Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lolis, D. | en |
| dc.contributor.author | Georgiou, I. | en |
| dc.contributor.author | Loizou, P. | en |
| dc.contributor.author | Makrydimas, G. | en |
| dc.contributor.author | Bairaktari, E. | en |
| dc.contributor.author | Tsolas, O. | en |
| dc.date.accessioned | 2015-11-24T19:36:45Z | - |
| dc.date.available | 2015-11-24T19:36:45Z | - |
| dc.identifier.issn | 0378-7346 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/23933 | - |
| dc.rights | Default Licence | - |
| dc.subject | Amniotic Fluid/*chemistry/metabolism | en |
| dc.subject | Anencephaly/diagnosis/metabolism | en |
| dc.subject | Biological Markers/analysis | en |
| dc.subject | Congenital Abnormalities/*diagnosis/metabolism | en |
| dc.subject | Cross-Sectional Studies | en |
| dc.subject | Female | en |
| dc.subject | Fetal Diseases/*diagnosis/metabolism | en |
| dc.subject | Fetal Growth Retardation/diagnosis/metabolism | en |
| dc.subject | Humans | en |
| dc.subject | Prealbumin/*analysis/metabolism | en |
| dc.subject | Pregnancy | en |
| dc.subject | Pregnancy Trimester, Second | en |
| dc.subject | Pregnancy Trimester, Third | en |
| dc.subject | Reference Values | en |
| dc.subject | Spinal Dysraphism/diagnosis/metabolism | en |
| dc.title | Amniotic fluid prealbumin as a potential marker of fetal abnormalities | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/8586303 | - |
| heal.identifier.secondary | http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000292343 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 1995 | - |
| heal.abstract | Normal amniotic fluid prealbumin (PAB) levels between 16 and 41 weeks of pregnancy are demonstrated in 175 samples from various gestational ages. PAB was measured quantitatively by immunonephelometry and qualitatively estimated by electrophoresis while total protein content was measured by colorimetry. The percent of PAB values in the total protein content is inversely correlated to the gestational age. Fetal abnormalities and abnormal conditions in pregnancy diagnosed in the second trimester and early third trimester (16-32 weeks) show significantly (p < 0.01) higher than expected PAB values (25.9 +/- 4.6 mg/l, range 19.5-35.6, n = 23) in comparison to normal fetuses and normal pregnancies of the same age (13.6 +/- 3.6 mg/l, range 4.3-19.8, n = 87). The remaining 65 samples of normal third trimester amniotic fluid were evaluated in comparison to the second trimester normal values, and inverse correlation in respect to advancing pregnancy was observed. PAB values were corrected for the total protein content and the resulting ratio had the lowest variation compared to PAB and total protein values. It is proposed that PAB, although not specific for a particular disorder, expressed as a ratio of the total protein content is a potential biochemical marker for certain fetal defects and complications of pregnancy. | en |
| heal.journalName | Gynecol Obstet Invest | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
